Dr. Markus Gershater explains how High Dimensional Experimentation (HDE) revolutionizes assay development by replacing one-factor-at-a-time (OFAT) methods with automated, multivariate workflows.

One of the hardest things to do when you establish an experiment that requires the measurement of proteins, cytokines, or biomarkers is the selection of the appropriate assay kit. Product catalogs are ...

Researchers from St Petersburg University and other scientific organizations have developed a method to identify inhibitors of the enzyme responsible for coronavirus replication. While investigating ...

Patent covers pristine graphene–based biosensor technology to translate protease activity into measurable optical ...

Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...

Learn about automation's vital role in drug discovery, offering increased scale and precision for research teams.

A German CDO Supporting Biotech Companies Bringing Biologics from Early Development to ClinicMELBOURNE, Australia, March 10, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” ...

This quarter, MindWalk Holdings Corp. reported its third consecutive year-over-year revenue increase and advanced three ...

Thank you for joining us today for MindWalk Holdings Corp.'s Third Quarter Fiscal Year 2026 Earnings Call. MindWalk trades on the NASDAQ under the ticker HYFT. Today's call will be led by our Chief ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...